Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The company returns high margins, thereby supporting business profitability.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 339.76 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 423.57.
  • The stock is close to a major daily resistance at USD 419.09, which should be gotten rid of so as to gain new appreciation potential.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company benefits from high valuations in earnings multiples.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
THERMO FISHER SCIENTIFIC27.97%164 454
DANAHER CORPORATION34.27%146 727
INTUITIVE SURGICAL, INC.15.62%80 214
SHENZHEN MINDRAY BIO-MEDICA..87.75%60 074
ILLUMINA, INC.18.67%56 178
BOSTON SCIENTIFIC CORPORATI..-17.85%54 146
EDWARDS LIFESCIENCES CORPOR..-1.50%48 508
KONINKLIJKE PHILIPS N.V.4.55%47 651
SIEMENS HEALTHINEERS AG-4.86%46 901
AGILENT TECHNOLOGIES, INC.14.32%30 597
RESMED, INC.30.84%29 223
OLYMPUS CORPORATION14.86%23 395
CERNER CORPORATION-6.10%21 209
HOLOGIC, INC.38.02%18 072
VARIAN MEDICAL SYSTEMS, INC..22.88%15 817
PERKINELMER, INC.24.43%13 563
More Results
Financials (USD)
Sales 2020 28 041 M - -
Net income 2020 4 456 M - -
Net Debt 2020 12 658 M - -
P/E ratio 2020 37,1x
Yield 2020 0,21%
Capitalization 164 B 164 B -
EV / Sales 2020 6,32x
EV / Sales 2021 5,94x
Nbr of Employees 75 000
Free-Float 90,6%
Upcoming event on THERMO FISHER SCIENTIFIC
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes